Legal Representation
Attorney
Janina Gorbach
USPTO Deadlines
Next Deadline
220 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
February 18, 2026
Extension Available
Until February 18, 2026
Application History
12 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 3, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jul 2, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jul 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 27, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Nov 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 16, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for treatment of dermatomyositis and lupus
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO